Compare Tangible Book Value Per Share Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Tangible Book Value Per Share Analysis
Compare Crinetics Pharmaceuticals, Viridian Therapeutics, and Cytokinetics Tangible Book Value Per Share Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRNX | (0.447) | (0.447) | (0.447) | (0.447) | (0.447) | (0.447) | (0.447) | (1.0824) | 13.1959 | 4.8455 | 5.5478 | 8.6363 | 6.0853 | 9.2836 | 9.75 |
| VRDN | (115) | (115) | (115) | 10.7727 | 39.8364 | 19.2976 | (0.4519) | 30.0162 | 26.0186 | 7.5411 | 33.7461 | 15.7497 | 12.3122 | 9.8764 | 5.97 |
| CYTK | (136) | 4.0829 | 3.9454 | 1.996 | 2.5782 | 1.7741 | 2.3624 | 2.2233 | 0.4766 | (0.19) | 1.7572 | 3.1717 | (1.2012) | (4.0024) | (4.2) |
| GPCR | (6.0E-4) | (6.0E-4) | (6.0E-4) | (6.0E-4) | (6.0E-4) | (6.0E-4) | (6.0E-4) | (6.0E-4) | (6.0E-4) | (6.0E-4) | (6.0E-4) | (0.0018) | (3.1469) | 12.3316 | 12.95 |
| KURA | (0.0037) | (0.0136) | (0.0191) | (0.0248) | (24.3475) | 8.2657 | 3.0413 | 3.437 | 4.5746 | 5.2158 | 11.5098 | 7.6352 | 6.2737 | 5.4251 | 5.7 |
| PTGX | 1.3518 | 1.3518 | 1.3518 | 1.3518 | 1.3518 | 1.6306 | 13.4663 | 6.8175 | 5.0511 | 3.1055 | 8.1592 | 6.4767 | (10.9448) | 5.9312 | 4.51 |
| MRUS | 0.6367 | 0.6367 | 0.6367 | 0.6367 | (0.3201) | 1.9775 | 2.6757 | 2.9733 | 4.5899 | 5.3028 | 3.3983 | 8.1228 | 5.4566 | 6.8121 | 7.15 |
| REPL | (0.5354) | (0.5354) | (0.5354) | (0.5354) | (0.5354) | (0.5354) | (0.5354) | (0.9102) | 5.9425 | 5.3622 | 10.7835 | 7.8761 | 9.539 | 5.6258 | 4.37 |
| ENTA | (114) | 37.9335 | 11.2861 | 8.0988 | 12.647 | 14.2604 | 15.8227 | 19.0644 | 23.6158 | 22.8475 | 19.9048 | 15.8479 | 10.336 | 6.0885 | 5.93 |
| SNDX | (0.4167) | (0.4167) | (0.4167) | 1.4797 | (0.5956) | 3.8392 | 5.7552 | 4.9682 | 2.0908 | 1.0364 | 6.105 | 7.8435 | 7.6933 | 7.8754 | 8.27 |
Crinetics Pharmaceuticals, Viridian Therapeutics, and Cytokinetics Tangible Book Value Per Share description
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Social Domain Invested few shares | |
 | Cash Cows Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | FinTech Invested over 60 shares | |
 | Macroaxis Index Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Driverless Cars Invested over 200 shares | |
 | Artificial Intelligence Invested few shares | |
 | Momentum Invested over 40 shares | |
 | Macroaxis Picks Invested few shares | |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world |